PLAU and cervical cancer: In our current study, we found that fisetin inhibits the activity of p38 to reduce invasion and migration through down-regulation of uPA without significantly altering proliferation in cervical cancer cells, suggesting that the roles of fisetin-regulated p38 might be dominant in aggressive phenotypes (invasion and migration) rather than proliferation in cervical cancer cells.